VC FundEIF
🇧🇪 CD3 II (Centre for Drug Design and Discovery)
KU Leuven Research & Development · Belgium
Focus
Health & Bio
EIF sector
Life Science
About CD3 II (Centre for Drug Design and Discovery)
CD3 II is a life-science fund run by the Centre for Drug Design and Discovery, the drug-discovery investment vehicle set up by KU Leuven Research & Development in Leuven, Belgium. It invests in early drug-discovery projects, academic spin-offs and biotechs across Europe, pairing capital with an in-house drug-discovery team. It is backed by the European Investment Fund alongside KU Leuven.
Notable portfolio
30+ drug discovery projects and biotech spinoffs across virology, oncology, CNS, and auto-immune research
EUACC IntelligenceFree preview
EUACC Intelligence
Ask about CD3 II (Centre for Drug Design and Discovery)
Get instant answers about CD3 II (Centre for Drug Design and Discovery) and how it fits your raise.